ME01992B
(en )
2012-10-30
Diarylhydantoin compounds
RS54123B1
(en )
2015-12-31
Therapeutic combination comprising dolutegravir, abacavir and lamivudine
DK1853602T3
(en )
2010-09-20
Chemical compounds
DK1853588T3
(en )
2008-09-15
Chemical compounds
ES2422557T3
(en )
2013-09-12
Compounds and compositions as modulators of the Hedgehog route
CR10157A
(en )
2008-10-29
CHEMICAL COMPOUNDS
RS52534B
(en )
2013-04-30
Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
RS54485B1
(en )
2016-06-30
C7-fluoro substituted tetracycline compounds
ATE441630T1
(en )
2009-09-15
SUBSTITUTED CYCLOPENT COMPOUNDS
RS52255B
(en )
2012-10-31
Nalmefene hydrochloride dihydrate
WO2007009721A3
(en )
2007-03-29
Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
BRPI0714885B8
(en )
2021-05-25
therapeutic compounds and their use
TW200745039A
(en )
2007-12-16
Isotopically substituted pantoprazole
NO20080412L
(en )
2008-03-18
New physiological compound Nesfatin, compound relevant thereto and use of the compounds
WO2006127379A3
(en )
2007-02-22
Par2-modulating compounds and their use
UY30788A1
(en )
2008-07-31
CHEMICAL COMPOUNDS
DE602006002608D1
(en )
2008-10-16
4-PHENYL-5-OXO-L, 4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES AS A MEDICAMENT FOR THE TREATMENT OF BARRENESS
TW200744612A
(en )
2007-12-16
New combination
PA8646301A1
(en )
2006-09-08
INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE
WO2009018551A3
(en )
2009-03-19
Therapeutic compounds
RU2006107361A
(en )
2007-09-20
HEMATOPROTECTIVE ACTION
EP2183256A4
(en )
2011-09-28
Therapeutic compounds
TH95090B
(en )
2009-04-09
Piroll derivatives, their preparations And therapeutic use
NO20083352L
(en )
2008-07-30
2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
RS53747B1
(en )
2015-06-30
Phenanthrenone compounds, compositions and methods